Back to list
Ligand:__F...
FLUORIDE ION
F
Compound type: non-polymer
Links: Het group HIC-Up NIST
CAS Registry Number: 14762-94-8
The following list shows the 845 PDB entries that contain one or more instances of ligand __F. Where the structure contains more than one instance, the count is shown in brackets after the protein name.
1 | 241 | ..Next | Last
.PDB.Id
Title
16pk* Phosphoglycerate kinase from trypanosoma brucei bisubstrate analog (x4)
1a08* C- src (sh2 domain) complexed with ace- difluoro phosphotyr- glu- (n,n- dipentyl amine) (x4)
1a29* Calmodulin complexed with trifluoperazine (1:2 complex) (x6)
1a2n* Structure of the c115a mutant of mura complexed with the fluorinated analog of the reaction tetrahedral intermediate
1a3t* Staphylococcal nuclease, v23c variant, complex with 2- fluoroethane thiol and 3',5'- thymidine diphosphate
1a50* Crystal structure of wild- type tryptophan synthase complexed with 5- fluoroindole propanol phosphate
1a5s* Crystal structure of wild- type tryptophan synthase complexed with 5- fluoroindole propanol phosphate and l- ser bound as amino acrylate to the beta site
1a6e* Thermosome - mg- adp- alf3 complex (x6)
1a71* Ternary complex of an active site double mutant of horse liver alcohol dehydrogenase, phe93=>trp, val203=>ala with NAD and trifluoroethanol (x6)
1ad8* Complex of thrombin with and inhibitor containing a novel p1 moiety (x5)
1ae4* Aldehyde reductase complexed with cofactor and inhibitor, alpha carbon atoms only (x3)
1afq* Crystal structure of bovine gamma- chymotrypsin complexed with a synthetic inhibitor (x2)
1agr* Complex of alf4- activated gi- alpha- 1 with rgs4 (x8)
1ah0* Pig aldose reductase complexed with sorbinil
1ah3* Aldose reductase complexed with tolrestat inhibitor (x3)
1aid* Structure of a non- peptide inhibitor complexed with HIV- 1 protease: developing a cycle of structure- based drug design (x2)
1amn* Transition state analog: acetylcholinesterase complexed with m- (n,n,n- trimethylammonio)trifluoroacetophenone (x3)
1apv* Acid proteinase (penicillopepsin) complex with a tetrahedral transition state mimic inhibitor: isovaleryl (iva)- val- val- hydrated difluorostatone- n- methylamide (x2)
1apw* Acid proteinase (penicillopepsin) complex with a tetrahedral transition state mimic inhibitor: isovaleryl (iva)- val- val- difluorostatine- n- methylamide (x2)
1axe* Crystal structure of the active- site mutant phe93- >trp of horse liver alcohol dehydrogenase in complex with NAD and inhibitor trifluoroethanol (x6)
1axg* Crystal structure of the val203- >ala mutant of liver alcohol dehydrogenase complexed with cofactor NAD and inhibitor trifluoroethanol solved to 2.5 angstrom resolution (x12)
1b02* Crystal structure of thymidylate synthase a from bacillus subtilis
1b0e* Crystal structure of porcine pancreatic elastase with mdl 101,146 (x5)
1b0f* Crystal structure of human neutrophil elastase with mdl 101, 146 (x5)
1b99* 3'- fluoro- uridine diphosphate binding to nucleoside diphosphate kinase
1bcd* X- ray crystallographic structure of a complex between human carbonic anhydrase ii and a new topical inhibitor, trifluoromethane sulphonamide (x3)
1bjg* D221(169)n mutant does not promote opening of the cofactor imidazolidine ring
1bm7* Human transthyretin (prealbumin) complex with flufenamic acid (2- [[3- (trifluoromethyl)phenyl]amino] benzoic acid) (x6)
1bma* Benzyl methyl aminimide inhibitor complexed to porcine pancreatic elastase (x3)
1br1* Smooth muscle myosin motor domain- essential light chain complex with mgadp.Alf4 bound at the active site (x16)
1br2* Smooth muscle myosin motor domain complexed with mgadp.Alf4 (x24)
1br4* Smooth muscle myosin motor domain- essential light chain complex with mgadp.Bef3 bound at the active site (x12)
1bs1* Dethiobiotin synthetase complexed with dethiobiotin, adp , inorganic phosphate and magnesium (x3)
1bs3* P.Shermanii sod(fe+3) fluoride (x2)
1bvv* Sugar ring distortion in the glycosyl- enzyme intermediate of a family g/11 xylanase
1bw7* Solution structure of a DNA duplex containing a replicable difluorotoluene- adenine pair (x2)
1bwf* Escherichia coli glycerol kinase mutant with bound atp analog showing substantial domain motion (x4)
1bx9* Glutathione s- transferase in complex with herbicide
1bzc* Human ptp1b catalytic domain complexed with tpi (x2)
1bzh* Cyclic peptide inhibitor of human ptp1b
1bzj* Human ptp1b complexed with tpicooh (x2)
1c0l* D- amino acid oxidase: structure of substrate complexes at very high resolution reveal the chemical reacttion mechanism of flavin dehydrogenation (x3)
1c50* Identification and structural characterization of a novel allosteric binding site of glycogen phosphorylase b
1c5i* Hydrogen bonding and catalysis: an unexpected explanation for how a single amino acid substitution can change the ph optimum of a glycosidase
1c8m* Refined crystal structure of human rhinovirus 16 complexed with vp63843 (pleconaril), an anti- picornaviral drug currently in clinical trials (x3)
1c9d* Crystal structure of the complex of bacterial tryptophan synthase with the transition state analogue inhibitor 4- (2- hydroxy- 4- fluorophenylthio)- butylphosphonic acid
1cqe* Prostaglandin h2 synthase- 1 complex with flurbiprofen (x2)
1cqq* Type 2 rhinovirus 3c protease with ag7088 inhibitor
1csr* Alpha- fluoro acid and alpha- fluoro amide analogs of acetyl- coa as inhibitors of of citrate synthase: effect of pka matching on binding affinity and hydrogen bond length
1css* Alpha- fluoro acid and alpha- fluoro amide analogs of acetyl- coa as inhibitors of of citrate synthase: effect of pka matching on binding affinity and hydrogen bond length
1ct8* Catalytic antibody 7c8 complex (x6)
1ctr* Drug binding by calmodulin: crystal structure of a calmodulin- trifluoperazine complex (x3)
1cu7* Bovine trypsin complexed with 2- [3- amino(iminomethyl) phenoxy]- 6- [3- (aminomethyl)phenoxy]- 3,5- difluoro- 4- methylpyridine (zk- 806299), binding model from double redor nmr and md simulations (x2)
1cu8* Bovine trypsin complexed with 2,6- bis[3- amino(imino)methyl phenoxy]- 3,5- difluoro- 4- methylpyridine (zk- 805623), binding model from double redor nmr and md simulations (x2)
1cu9* Bovine trypsin complexed with 2,6- bis[3- amino(imino)methyl phenoxy]- 3,5- difluoro- 4- methylpyridine (zk- 805623), binding model from double redor nmr and md simulations (x2)
1cx2* Cyclooxygenase- 2 (prostaglandin synthase- 2) complexed with a selective inhibitor, sc- 558 (x12)
1cxl* Complex between a covalent intermediate and bacillus circulans strain 251 cgtase e257q (x2)
1d0x* Dictyostelium myosin s1dc (motor domain fragment) complexed with m- nitrophenyl aminoethyldiphosphate beryllium trifluoride. (x3)
1d0y* Dictyostelium myosin s1dc (motor domain fragment) complexed with o- nitrophenyl aminoethyldiphosphate beryllium fluoride (x3)
1d0z* Dictyostelium myosin s1dc (motor domain fragment) complexed with p- nitrophenyl aminoethyldiphosphate beryllium trifluoride. (x3)
1d1a* Dictyostelium myosin s1dc (motor domain fragment) complexed with o,p- dinitrophenyl aminoethyldiphosphate beryllium trifluoride. (x3)
1d1b* Dictyostelium myosin s1dc (motor domain fragment) complexed with o,p- dinitrophenyl aminopropyldiphosphate beryllium trifluoride. (x3)
1d1c* Dictyostelium myosin s1dc (motor domain fragment) complexed with n- methyl- o- nitrophenyl aminoethyldiphosphate beryllium trifluoride. (x3)
1d3g* Human dihydroorotate dehydrogenase complexed with brequinar analog
1d3h* Human dihydroorotate dehydrogenase complexed with antiproliferative agent a771726 (x3)
1d4j* HIV- 1 protease in complex with the inhibitor msl370
1d4s* HIV- 1 protease v82f/i84v double mutant/tipranavir complex (x3)
1d4y* HIV- 1 protease triple mutant/tipranavir complex (x3)
1dct* DNA (cytosine- 5) methylase from haeiii covalently bound to DNA (x2)
1dif* HIV- 1 protease in complex with a difluoroketone containing inhibitor a79285 (x2)
1dl8* Crystal structure of 5- f- 9- amino- (n- (2- dimethylamino)ethyl) acridine- 4- carboxamide bound to d(cgtacg)2 (x2)
1dnf* DNA (5(prime)- d(cp Gp Cp Gp U Fp Gp)- 3(prime)) (x2)
1dpn* B- dodecamer cgcgaa(taf)tcgcg with incorporated 2'- deoxy- 2'- fluoro- arabino- furanosyl thymine (x2)
1dtq* Crystal structure of HIV- 1 reverse transcriptase in complex with pett- 1 (pett131a94)
1dtt* Crystal structure of HIV- 1 reverse transcriptase in complex with pett- 2 (pett130a94)
1dvr* Adenylate kinase. Synonym: atp:amp- phosphotransferase, myokinase. Mutation: d89v, r165i (x4)
1dvt* Crystal structure of human transthyretin in complex with flurbiprofen
1dvy* Crystal structure of transthyretin in complex with n- (m- trifluoromethylphenyl) phenoxazine- 4,6- dicarboxylic acid (x3)
1dvz* Crystal structure of human transthyretin in complex with o- trifluoromethylphenyl anthranilic acid (x3)
1dy8* Inhibition of the hepatitis c virus ns3/4a protease. The crystal structures of two protease- inhibitor complexes (inhibitor ii) (x4)
1dy9* Inhibition of the hepatitis c virus ns3/4a protease. The crystal structures of two protease- inhibitor complexes (inhibitor i) (x4)
1e0v* Xylanase 10a from sreptomyces lividans. Cellobiosyl- enzyme intermediate at 1.7 a
1e0x* Xylanase 10a from sreptomyces lividans. Xylobiosyl- enzyme intermediate at 1.65 a (x2)
1e0y* Structure of the d170s/t457e double mutant of vanillyl- alcohol oxidase (x3)
1e1r* Bovine mitochondrial f1- atpase inhibited by mg2+adp and aluminium fluoride (x3)
1e2e* Human thymidylate kinase complexed with thymidine monophosphate, adenosine diphosphate,a magnesium- ion and alf3 (x3)
1e4i* 2- deoxy- 2- fluoro- beta- d- glucosyl/enzyme intermediate complex of the beta- glucosidase from bacillus polymyxa (x2)
1e6a* Fluoride- inhibited substrate complex of saccharomyces cerevisiae inorganic pyrophosphatase (x2)
1e70* 2- f- glucosylated myrosinase from sinapis alba
1e73* 2- f- glucosylated myrosinase from sinapis alba with bound l- ascorbate
1e7b* Crystal structure of human serum albumin complexed with the general anesthetic halothane (x18)
1e7c* Human serum albumin complexed with myristic acid and the general anesthetic halothane (x21)
1e8g* Structure of the h61t double mutant of vanillyl- alcohol oxidase in complex with fluoro- cresol (x6)
1ea1* Cytochrome p450 14 alpha- sterol demethylase (cyp51) from mycobacterium tuberculosis in complex with fluconazole (x2)
1eas* Nonpeptidic inhibitors of human leukocyte elastase. 3. Design, synthesis, x- ray crystallographic analysis, and structure- activity relationships for a series of orally active 3- amino- 6- phenylpyridin- 2- one trifluoromethyl ketones (x3)
1eat* Nonpeptidic inhibitors of human leukocyte elastase. 5. Design, synthesis, and x- ray crystallography of a series of orally active 5- amino- pyrimidin- 6- one- containing trifluoromethylketones (x3)
1eau* Nonpeptidic inhibitors of human leukocyte elastase. 6. Design of a potent, intratracheally active, pyridone- based trifluoromethyl ketone (x2)
1ec0* HIV- 1 protease in complex with the inhibitor bea403 (x2)
1eek* Solution structure of a nonpolar, non hydrogen bonded base pair surrogate in DNA. (x2)
1eet* HIV- 1 reverse transcriptase in complex with the inhibitor msc204
1ef3* Fidarestat bound to human aldose reductase (x2)
1ela* Elastase complexed with trifluoroacetyl- l- lysyl- l- prolyl- p- isopropylanilide (x3)
1elb* Elastase complexed with trifluoroacetyl- l- lysyl- l- leucyl- p- isopropylanilide (x3)
1elc* Elastase complexed with trifluoroacetyl- l- phenylalanyl- p- isopropylanilide (x3)
1eld* Elastase complexed with trifluoroacetyl- l- phenylalanyl- l- alanyl- p- trifluoromethylaninide (tfa- phe- ala- tfm) (x6)
1ele* Elastase complexed with trifluoroacetyl- l- valyl- l- alanyl- p- trifluoromethylaninide (tfa- val- ala- tfm) (x6)
1epo* Endothia aspartic proteinase (endothiapepsin) complexed with cp- 81,282 (mor phe nle chf nme) (x2)
1epr* Endothia aspartic proteinase (endothiapepsin) complexed with pd- 135,040 (tsm dph his chf emr) (x2)
1eqh* The 2.7 angstrom model of ovine cox- 1 complexed with flurbiprofen (x2)
1exa* Enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the active r- enantiomer bms270394.
1exp* Beta- 1,4- glycanase cex- cd
1exx* Enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the inactive s- enantiomer bms270395.
1f4v* Crystal structure of activated chey bound to the n- terminus of flim (x9)
1fc8* Nmr solution structure of a chimeric oligonucleotide hairpin r(ggac)d(ttcg)2'f- a(gtcc) (x4)
1fdk* Carboxylic ester hydrolase (pla2- mj33 inhibitor complex) (x3)
1fjs* Crystal structure of the inhibitor zk- 807834 (ci- 1031) complexed with factor xa (x2)
1fk9* Crystal structure of HIV- 1 reverse transcriptase in complex with dmp- 266(efavirenz) (x3)
1fko* Crystal structure of nnrti resistant k103n mutant HIV- 1 reverse transcriptase in complex with dmp- 266(efavirenz) (x3)
1fq8* X- ray structure of difluorostatine inhibitor cp81,198 bound to saccharopepsin (x2)
1fqj* Crystal structure of the heterotrimeric complex of the rgs domain of rgs9, the gamma subunit of phosphodiesterase and the gt/i1 chimera alpha subunit [(rgs9)- (pdegamma)- (gt/i1alpha)- (gdp)- (alf4- )- (mg2+)] (x8)
1fqk* Crystal structure of the heterodimeric complex of the rgs domain of rgs9, and the gt/i1 chimera alpha subunit [(rgs9) (gt/i1alpha)- (gdp)- (alf4- )- (mg2+)] (x8)
1fqw* Crystal structure of activated chey (x6)
1frb* Fr- 1 protein/NADPH/zopolrestat complex (x3)
1fuy* Crystal structure of betaa169l/betac170w double mutant of tryptophan synthase complexed with 5- fluoro- indole- propanol phosphate
1fx9* Carboxylic ester hydrolase complex (dimeric pla2 + mj33 inhibitor + sulphate ions) (x3)
1fxf* Carboxylic ester hydrolase complex (dimeric pla2 + mj33 inhibitor + phosphate ions) (x3)
1g18* Reca- adp- alf4 complex (x4)
1g1d* Carbonic anhydrase ii complexed with 4- (aminosulfonyl)- n- [(2- fluorophenyl)methyl]- benzamide
1g45* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2- fluorophenyl)methyl]- benzamide
1g46* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2,3- difluorophenyl)methyl]- benzamide (x2)
1g48* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2,6- difluorophenyl)methyl]- benzamide (x2)
1g4j* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2,3,4,5,6- pentafluorophenyl)methyl]- benzamide (x10)
1g4p* Thiamin phosphate synthase (x6)
1g4t* Thiamin phosphate synthase (x6)
1g4u* Crystal structure of the salmonella tyrosine phosphatase and gtpase activating protein sptp bound to rac1 (x3)
1g52* Carbonic anhydrase ii complexed with 4- (aminosulfonyl)- n- [(2,3- difluorophenyl)methyl]- benzamide (x2)
1g53* Carbonic anhydrase ii complexed with 4- (aminosulfonyl)- n- [(2,6- difluorophenyl)methyl]- benzamide (x2)
1g54* Carbonic anhydrase ii complexed with 4- (aminosulfonyl)- n- [(2,3,4,5,6- pentafluorophenyl)methyl]- benzamide (x5)
1g6c* Thiamin phosphate synthase (x6)
1g6u* Crystal structure of a domain swapped dimer (x3)
1g9r* Crystal structure of galactosyltransferase lgtc in complex with mn and udp- 2f- galactose
1ga8* Crystal structure of galacosyltransferase lgtc in complex with donor and acceptor sugar analogs.
1gfi* Structures of active conformations of gi alpha 1 and the mechanism of gtp hydrolysis (x4)
1gg6* Crystal stucture of gamma chymotrypsin with n- acetyl- phenylalanine trifluoromethyl ketone bound at the active site (x6)
1gj8* Engineering inhibitors highly selective for the s1 sites of ser190 trypsin- like serine protease drug targets
1gj9* Engineering inhibitors highly selective for the s1 sites of ser190 trypsin- like serine protease drug targets
1grn* Crystal structure of the cdc42/cdc42gap/alf3 complex. (x3)
1gs4* Structural basis for the glucocorticoid response in a mutant human androgen receptor (arccr) derived from an androgen- independent prostate cancer
1gsz* Crystal structure of a squalene cyclase in complex with the potential anticholesteremic drug ro48- 8071 (x3)
1gvy* Substrate distorsion by beta- mannanase from pseudomonas cellulosa
1gw1* Substrate distortion by beta- mannanase from pseudomonas cellulosa (x2)
1gwx* Molecular recognition of fatty acids by peroxisome proliferator- activated receptors (x2)
1gyy* The crystal structure of ydce, a 4- oxalocrotonate tautomerase homologue from escherichia coli, confirms the structural basis for oligomer diversity (x2)
1gzg* Complex of a mg2- dependent porphobilinogen synthase from pseudomonas aeruginosa (mutant d139n) with 5- fluorolevulinic acid (x4)
1h00* Cdk2 in complex with a disubstituted 4, 6- bis anilino pyrimidine cdk4 inhibitor (x4)
1h06* Cdk2 in complex with a disubstituted 4, 6- bis anilino pyrimidine cdk4 inhibitor (x8)
1h11* 2- deoxy- 2- fluro- b- d- cellotriosyl/enzyme intermediate complex of the endoglucanase cel5a from bacillus agaradhearans at 1.08 angstrom resolution
1h1d* Catechol o- methyltransferase (x3)
1h2j* Endoglucanase cel5a in complex with unhydrolysed and covalently linked 2,4- dinitrophenyl- 2- deoxy- 2- fluoro- cellobioside at 1.15 a resolution
1h3a* Structures of human oxidosqualene cyclase inhibitors bound to a homolgous enzyme (x3)
1h4g* Oligosaccharide- binding to family 11 xylanases: both covalent intermediate and mutant- product complexes display 2,5b conformations at the active- centre (x2)
1h5u* The 1.76 a resolution crystal structure of glycogen phosphorylase b complexed with glucose and cp320626, a potential antidiabetic drug
1h6m* Covalent glycosyl- enzyme intermediate of hen egg white lysozyme
1h7x* Dihydropyrimidine dehydrogenase (dpd) from pig, ternary complex of a mutant enzyme (c671a), NADPH and 5- fluorouracil (x4)
1h8e* (Adp.Alf4)2(adp.So4) bovine f1- atpase (all three catalytic sites occupied) (x8)
1hbj* X- ray crystal structure of complex between torpedo californica ache and a reversible inhibitor, 4- amino- 5- fluo ro- 2- methyl- 3- (3- trifluoroacetylbenzylthiomethyl)quinoline (x4)
1he1* Crystal structure of the complex between the gap domain of the pseudomonas aeruginosa exos toxin and human rac (x6)
1hf5* 2- deoxy- 2- fluro- b- d- cellotriosyl/enzyme intermediate complex of the endoglucanase cel5a from bacillus agaradhearans at 1.08 angstrom resolution
1hf7* Endoglucanase cel5a from bacillus agaradhaerens in the orthorhombic crystal form in complex with unhydrolysed and covalently linked 2,4- dinitrophenyl- 2- deoxy- 2fluoro- cellobioside at 1.15 a resolution (x2)
1hfs* Crystal structure of the catalytic domain of human fibroblast stromelysin- 1 inhibited with the n- carboxy- alkyl inhibitor l- 764,004
1hl9* Crystal structure of thermotoga maritima alpha- fucosidase in complex with a mechanism based inhibitor (x2)
1hld* Alcohol dehydrogenase (ee isozyme) complexed with nicotinamide adenine dinucleotide (NAD), 2,3,4,5,6- penta- fluorobenzyl alcohol, p- bromobenzyl alcohol and zinc (x10)
1hn4* Prophospholipase a2 dimer complexed with mj33, sulfate, and calcium (x3)
1ht5* The 2.75 angstrom resolution model of ovine cox- 1 complexed with methyl ester flurbiprofen (x2)
1hwi* Complex of the catalytic portion of human hmg- coa reductase with fluvastatin (x4)
1hwj* Complex of the catalytic portion of human hmg- coa reductase with cerivastatin (x4)
1hwk* Complex of the catalytic portion of human hmg- coa reductase with atorvastatin (x4)
1hwl* Complex of the catalytic portion of human hmg- coa reductase with rosuvastatin (formally known as zd4522) (x4)
1hyx* High resolution crystal structure of the complex of the hydrolytic antibody fab 6d9 and a transition- state analog (x3)
1hyy* Crystal form ii: high resolution crystal structure of the complex of the hydrolytic antibody fab 6d9 and a transition- state analog (x3)
1i45* Yeast triosephosphate isomerase (mutant) (x2)
1i9l* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(4- fluorophenyl)methyl]- benzamide (x2)
1i9m* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2,4- difluorophenyl)methyl]- benzamide (x4)
1i9n* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2,5- difluorophenyl)methyl]- benzamide (x2)
1i9o* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2,3,4- trifluorophenyl)methyl]- benzamide (x6)
1i9p* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(2,4,6- trifluorophenyl)methyl]- benzamide (x3)
1i9q* Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)- n- [(3,4,5- trifluorophenyl)methyl]- benzamide (x6)
1icg* Structure of the hybrid RNA/DNA r- gcuucggc- d[f]u in presence of ir(nh3)6+++ (x2)
1id9* Structure of the hybrid RNA/DNA r- gcuucggc- d[f]u in presence of rh(nh3)6+++ (x2)
1iei* Crystal structure of human aldose reductase complexed with the inhibitor zenarestat.
1iew* Crystal structure of barley beta- d- glucan glucohydrolase isoenzyme exo1 in complex with 2- deoxy- 2- fluoro- alpha- d- glucoside
1if4* Carbonic anhydrase ii complexed with 4- fluorobenzenesulfonamide
1if5* Carbonic anhydrase ii complexed with 2,6- difluorobenzenesulfonamide (x2)
1if6* Carbonic anhydrase ii complexed with 3,5- difluorobenzenesulfonamide (x2)
1ihu* Crystal structure of the escherichia coli arsenite- translocating atpase in complex with mg- adp- alf3 (x3)
1ikv* K103n mutant HIV- 1 reverse transcriptase in complex with efivarenz (x3)
1ikw* Wild type HIV- 1 reverse transcriptase in complex with efavirenz (x3)
1j4r* Fk506 binding protein complexed with fkb- 001 (x6)
1j56* Minimized average structure of beryllofluoride- activated ntrc receiver domain: model structure incorporating active site contacts (x3)
1j97* Phospho- aspartyl intermediate analogue of phosphoserine phosphatase (x6)
1jdj* Crystal structure of leishmania mexicana glycerol- 3- phosphate dehydrogenase in complex with 2- fluoro- 6- chloropurine
1jkh* Crystal structure of y181c mutant HIV- 1 reverse transcriptase in complex with dmp- 266(efavirenz) (x3)
1jlc* Crystal structure of y181c mutant HIV- 1 reverse transcriptase in complex with pett- 2
1jxr* Structure of yeast proteinase a (x2)
1jyy* E. Coli (lacz) beta- galactosidase in complex with 2- f- lactose. Chains a- h, see remark 400. (x8)
1jyz* E. Coli (lacz) beta- galactosidase in complex with 2- f- lactose. Chains i- p, see remark 400. (x8)
1jz0* E. Coli (lacz) beta- galactosidase- trapped 2- f- galactosyl- enzyme intermediate. Chains a- h, see remark 400 (x8)
1jz1* E. Coli (lacz) beta- galactosidase- trapped 2- f- galactosyl- enzyme intermediate. Chains i- p, see remark 400 (x8)
1jz2* E. Coli (lacz) beta- galactosidase- trapped 2- f- galactosyl- enzyme intermediate (orthorhombic) (x4)
1k2o* Cytochrome p450cam with bound bis(2,2'- bipyridine)- (5- methyl- 2- 2'- bipyridine)- c2- adamantane ruthenium (ii) (x32)
1k2u* Structure of rat brain nnos heme domain complexed with s- ethyl- n- [4- (trifluoromethyl)phenyl] isothiourea (x6)
1k3c* Phosphoenolpyruvate carboxykinase in complex with adp, alf3 and pyruvate (x3)
1k3d* Phosphoenolpyruvate carboxykinase in complex with adp and alf3 (x3)
1k5g* Crystal structure of ran- gdp- alfx- ranbp1- rangap complex (x12)
1k8w* Crystal structure of the e. Coli pseudouridine synthase trub bound to a t stem- loop RNA
1kak* Human tyrosine phosphatase 1b complexed with an inhibitor (x4)
1kav* Human tyrosine phosphatase 1b complexed with an inhibitor (x4)
1kdn* Structure of nucleoside diphosphate kinase (x9)
1kh5* E. Coli alkaline phosphatase mutant (d330n) mimic of the transition states with aluminium fluoride (x6)
1kh9* E. Coli alkaline phosphatase mutant (d153gd330n) complex with phosphate (x6)
1khj* E. Coli alkaline phosphatase mutant (d153hd330n) mimic of the transition states with aluminium fluoride (x6)
1kjr* Crystal structure of the human galectin- 3 crd in complex with a 3'- derivative of n- acetyllactosamine (x4)
1kk8* Scallop myosin (s1- adp- befx) in the actin- detached conformation (x3)
1kkq* Crystal structure of the human ppar- alpha ligand- binding domain in complex with an antagonist gw6471 and a smrt corepressor motif (x12)
1kmi* Crystal structure of an e.Coli chemotaxis protein, chez (x3)
1krx* Solution structure of beryllofluoride- activated ntrc receiver domain: model structures incorporating active site contacts (x3)
1l3r* Crystal structure of a transition state mimic of the catalytic subunit of camp- dependent protein kinase (x3)
1l5y* Crystal structure of mg2+ / bef3- bound receiver domain of sinorhizobium meliloti dctd (x33)
1l7n* Transition state analogue of phosphoserine phosphatase (aluminum fluoride complex) (x14)
1lgw* T4 lysozyme mutant l99a/m102q bound by 2- fluoroaniline
1lgx* T4 lysozyme mutant l99a/m102q bound by 3,5- difluoroaniline (x2)
1lh5* X- ray structural investigation of leghemoglobin. Vi. Structure of acetate- ferrileghemoglobin at a resolution of 2.0 angstroms (russian)
1lin* Calmodulin complexed with trifluoperazine (1:4 complex) (x12)
1lqf* Structure of ptp1b in complex with a peptidic bisphosphonate inhibitor (x16)
1lvk* X- ray crystal structure of the mg (dot) 2'(3')- o- (n- methylanthraniloyl) nucleotide bound to dictyostelium discoideum myosin motor domain (x3)
1lwo* Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 a resolution
1m2z* Crystal structure of a dimer complex of the human glucocorticoid receptor ligand- binding domain bound to dexamethasone and a tif2 coactivator motif (x2)
1m34* Nitrogenase complex from azotobacter vinelandii stabilized by adp- tetrafluoroaluminate (x32)
1m7q* Crystal structure of p38 map kinase in complex with a dihydroquinazolinone inhibitor (x2)
1mar* Aldose reductase (x3)